Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels

Area of Science:

• Pharmacology
• Neuroscience
• Medicinal Chemistry

Background:

• Riluzole is a known sodium channel blocker.
• Developing new analogs can improve therapeutic properties.
• Skeletal muscle sodium channels are targets for treating excitability disorders.

Purpose of the Study:

• To evaluate novel riluzole analogs as voltage-gated skeletal muscle sodium channel blockers.
• To identify structure-activity relationships for improved potency and use-dependent blocking.
• To explore the potential of these compounds for treating cell excitability disorders.

Main Methods:

• In vitro evaluation of riluzole analogs using patch-clamp technique.
• Assessment of potency and use-dependent blocking.
• In vitro myotonia model.
• Molecular docking studies to identify binding site interactions.

Main Results:

• Potency of analogs correlated with lipophilicity.
• Protonatable amino function enhanced use-dependent behavior.
• Riluzole analog 14 showed greater use-dependent Nav1.4 blocking activity.
• Docking studies identified key interactions within the local anesthetic binding site.

Conclusions:

• Novel riluzole analogs, particularly analog 14, show promise as Nav1.4 blockers.
• Structure-activity relationships identified key features for enhanced use-dependent activity.
• These findings support the development of new treatments for cell excitability disorders.